Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
2
×
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
life sciences
madrigal pharmaceuticals
medicaid
2
×
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
2
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aducanumab
affordable care act
aldeyra therapeutics
alex azar
alzheimer's disease
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
What
drug
2
×
roundup
2
×
aducanumab
ahead
alzheimer’s
ambien
american
amyloid
angst
annual
asco
attendees
attention
bagged
billions
bio
biogen
biogen’s
biotech
brammer
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
days
effects
expanding
failure
felt
focus
home
key
kicks
lost
meeting
nash
Language
Current search:
medicaid
×
drug
×
photo
×
" san diego top stories "
×
" clinical trials "
×
roundup
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
